The treatment of skin immune diseases is one of the most successful cases in immunological translational medicine. With the application of biological agents, more and more patients are achieving the treatment goal of complete or almost complete clearance of skin lesions and itching. We still have many questions regarding the pharmaceutical mechanisms of biological agents, rational and safe use of drugs, long-term patient management, and early intervention. In order to promote the development of skin immune diseases, psoriasis, urticaria and other fields, improve the level of precision diagnosis and treatment, use biological agents reasonably and safely, manage chronic diseases throughout the process, and reduce the disease burden of patients, the academic conference on invasive skin diseases hosted by Chengdu High tech Medical Association was held online on May 28 and June 24, 2024. Representatives attending the conference expressed great benefits and hoped to participate in similar conferences in the future.